Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€6.55

€6.55

3.850%
0.25
3.850%
€7.50
 
20.03.24 / Tradegate WKN: A2JBKV / Symbol: PPHMD / Name: Avid Bio / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Avid Bioservices Inc Stock

Avid Bioservices Inc dominated the market today, gaining €0.25 (3.850%).
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Avid Bioservices Inc stock is not clear.
With a target price of 7 € there is a slightly positive potential of 6.87% for Avid Bioservices Inc compared to the current price of 6.55 €.

Pros and Cons of Avid Bioservices Inc in the next few years

Pros
?
B****
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Avid Bioservices Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Avid Bioservices Inc 3.850% - - - - - -
Gritstone Oncology Inc -6.610% -4.678% -6.857% 6.722% 31.593% -73.850% -
Rockwell Medical Inc. 1.330% 9.901% 25.121% -6.386% -12.795% -85.658% -97.163%
Innoviva Inc. 0.700% 2.899% -0.699% 36.538% -2.740% 42.000% -

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-11-13

A general assessment of Avid Bio’s (US symbol: PPHMD) financial metrics reveals a fairly stable pharmaceutical company. The metrics indicate a company with a consistent financial track record, although there are areas of concern. For instance, a PERatio of 31.9728 is on the high side, which flags a need for caution as higher PE ratios generally signal overpriced stocks. Nevertheless, before rushing to conclusions, a detailed probing into the pros and cons of Avid Bio’s financial statements is necessary.

Several indicators reflect positively on Avid Bio’s fiscal health. A notable highlight is the firm's Market Capitalization, standing at a sizeable 219.3842 million. This points to the market’s optimistic perception of Avid Bio, supporting the company’s overall growth potential and future economic prospects.

The Revenue per share TTM (Trailing Twelve Months) at 2.405 further strengthens Avid Bio’s position. This indicator, along with Quarterly Revenue Growth YOY (Year on Year) at 0.028, affirms the company's reliable revenue generation capacity. Correspondingly, a Gross Profit TTM of 31,480,000 showcases the operational success in terms of revenue realization after accounting for direct costs.